Liu et al. evaluated critically ill hospitalized patients with COVID-19 with bacterial infection and found that P. aeruginosa was the pneumonia organism that most commonly developed antimicrobial resistance, acquiring resistance to many broad-spectrum beta-lactam/beta-lactamase inhibitors, third-generation cephalosporins, and sometimes carbapenems [8]. Here, LACTB is linked to pneumonia.